SCHEMBL356196

SCHEMBL356196

CCN=C=NC(CC)N(CC)CC

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL756845 0.98 CYP1A2 (0.31) CYP1A2CYP2D6
SCHEMBL34280 0.80 CYP1A2 (0.38) CYP1A2CYP2D6
SCHEMBL2568072 0.80 CYP1A2 (0.38) CYP1A2CYP2D6
SCHEMBL252711 0.80
Hydrochloric Acid SCHEMBL153625 0.78 CYP1A2 (0.36) CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL5078995 0.78 CYP1A2 (0.36) CYP1A2CYP2D6
SCHEMBL21808585 0.78 CYP1A2 (0.36) CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL1071947 0.78 CYP1A2 (0.36) CYP1A2CYP2D6
SCHEMBL9725035 0.77 TRPA1 (0.46)
Iodomethane SCHEMBL898632 0.77 CYP1A2 (0.35) CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11560635-B2 Electrode for gas generation, method of preparing the electrode and device including the electrode for gas generation UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) 2023-01-24 US claimed
US-20200325586-A1 Electrode for Gas Generation, Method of Preparing the Electrode and Device Including the Electrode for Gas Generation UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) 2020-10-15 US claimed
EP-0664698-A1 METHOD FOR FORMING CONTROLLED RELEASE POLYMERIC SUBSTRATE VITAPHORE CORPORATION (US) 1995-08-02 EP claimed
WO-1995005162-A1 METHOD FOR FORMING CONTROLLED RELEASE POLYMERIC SUBSTRATE VITAPHORE CORPORATION (US) 1995-02-23 WO claimed
EP-0220657-B1 CONJUGATE OF 9-(2-HYDROXYETHOXYMETHYL)-GUANINE WITH LACTOSAMINATED HUMAN ALBUMIN, PROCESS FOR THE PEPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT LABORATORI BALDACCI Spa (IT) 1991-08-14 EP claimed
US-4725672-A HEPATITIS LABORATORI BALDACCI S.P.A. (IT) 1988-02-16 US claimed
EP-0220657-A2 Conjugate of 9-(2-hydroxyethoxymethyl)-guanine with lactosaminated human albumin, process for the peparation thereof and pharmaceutical compositions containing it LABORATORI BALDACCI Spa (IT) 1987-05-06 EP claimed
US-11851463-B2 Core domain of annexins and uses thereof in antigen delivery and vaccination Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2023-12-26 US disclosed
US-11560635-B2 Electrode for gas generation, method of preparing the electrode and device including the electrode for gas generation UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) 2023-01-24 US disclosed
CN-110036002-B Pharmaceutical compounds 细胞中心有限公司 2022-08-30 CN disclosed
US-11377443-B2 Pharmaceutical compounds CellCentric Limited (GB) 2022-07-05 US disclosed
CN-110049983-B Pharmaceutical compounds 细胞中心有限公司 2022-06-14 CN disclosed
EP-3943494-A1 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2022-01-26 EP disclosed
WO-1996002273-A1 HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS THE SCRIPPS RESEARCH INSTITUTE (US) 1996-02-01 WO disclosed
WO-1994004187-A1 METHOD FOR IMPROVING THE GROWTH AND THE QUALITY OF CARCASES OF DOMESTIC MEAT-PRODUCER ANIMALS, VACCINATION KIT ET VACCINES RHONE MERIEUX SOCIETE ANONYME (FR) 1994-03-03 WO disclosed
US-5196478-A Polystyrene, assays EPIPHARM ALLERGIE-SERVICE GESELLSCHAFT M.B.H. (AT) 1993-03-23 US disclosed
EP-0439585-A1 IMMOBILISATION OF LIGANDS BY RADIO-DERIVATIZED POLYMERS. EPIPHARM ALLERGIE SERVICE (AT) 1991-08-07 EP disclosed
WO-1991002768-A1 IMMOBILISATION OF LIGANDS BY RADIO-DERIVATIZED POLYMERS EPIPHARM ALLERGIE-SERVICE GESELLSCHAFT M.B.H. (AT) 1991-03-07 WO disclosed
US-4518590-A 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method PFIZER INC. (US) 1985-05-21 US disclosed
EP-0024510-B1 PHENOXYPROPYL AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM TEIKOKU HORMONE MFG. CO., LTD. (JP) 1983-10-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11377443-B2 Pharmaceutical compounds EP300, HDAC1, HDAC11 CYP1A2 2805/4885CYP2D6 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.